Shanghai Shyndec Pharmaceutical Co., Ltd. (SHA: 600420)

Shanghai Shyndec Pharmaceutical Revenue

Shanghai Shyndec Pharmaceutical had revenue of 2.63B CNY in the quarter ending September 30, 2024, a decrease of -3.10%. This brings the company's revenue in the last twelve months to 11.50B, down -7.26% year-over-year. In the year 2023, Shanghai Shyndec Pharmaceutical had annual revenue of 12.07B, down -6.86%.

• Revenue (ttm): 11.50B
• Revenue Growth: -7.26%
• P/S Ratio: 1.48
• Revenue / Employee: 990.81K
• Employees: 11,608
• Market Cap: 17.01B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	12.07B	-889.39M	-6.86%
Dec 31, 2022	12.96B	-985.63M	-7.07%
Dec 31, 2021	13.94B	1.39B	11.06%
Dec 31, 2020	12.56B	357.17M	2.93%
Dec 31, 2019	12.20B	878.33M	7.76%